tiprankstipranks
Trending News
More News >
Exponent (EXPO)
NASDAQ:EXPO
Advertisement

Exponent (EXPO) AI Stock Analysis

Compare
180 Followers

Top Page

EXPO

Exponent

(NASDAQ:EXPO)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
$77.00
▲(13.19% Upside)
Exponent's overall stock score reflects strong financial performance and strategic growth initiatives, tempered by high valuation and mixed technical indicators. The earnings call highlighted both opportunities and challenges, with strategic expansions and demand resilience offset by declines in net income and utilization. Investors should monitor cash flow management and market conditions closely.
Positive Factors
Revenue Growth
Exponent's strong revenue growth indicates robust demand for its services, supporting long-term business expansion and market penetration.
Strategic Expansion
Engagement in transformative innovations positions Exponent for future growth, leveraging emerging technologies to expand its market reach.
Strong Litigation-Related Activity
Growth in litigation-related activities highlights Exponent's strong position in high-demand sectors, ensuring steady revenue streams.
Negative Factors
Decline in Net Income
A decline in net income may impact Exponent's profitability, potentially affecting its ability to reinvest in growth and innovation.
Decline in Utilization
Reduced utilization and billable hours can limit revenue potential, indicating challenges in operational efficiency and resource management.
Environmental and Health Segment Challenges
Challenges in the environmental and health segment suggest potential revenue headwinds, impacting overall growth in these critical areas.

Exponent (EXPO) vs. SPDR S&P 500 ETF (SPY)

Exponent Business Overview & Revenue Model

Company DescriptionExponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
How the Company Makes MoneyExponent generates revenue through a subscription-based model for its software products, allowing customers to access its analytics tools and services on a recurring basis. The company also earns money through professional services, including consulting and support, which help clients implement and utilize their technologies effectively. Key revenue streams include subscriptions from enterprise clients, data integration services, and partnerships with other technology firms that enhance its product offerings. Additionally, Exponent may engage in strategic alliances that leverage its analytics capabilities, further driving sales and customer acquisition.

Exponent Earnings Call Summary

Earnings Call Date:Jul 31, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 23, 2025
Earnings Call Sentiment Neutral
The earnings call reflected a balanced view with strong demand in certain sectors and successful recruitment efforts countered by declines in net income, utilization, and specific segment revenues.
Q2-2025 Updates
Positive Updates
Resilience in Demand for Failure Analysis
Despite flat overall revenues, demand for failure analysis expertise drove growth in dispute-related activities, particularly in construction, automotive, and medical device sectors.
Headcount Growth and Recruitment Success
Exponent narrowed the headcount gap from a 5-6% deficit at the beginning of the year to 2% by the end of the second quarter, expecting further increases in the third and fourth quarters.
Strong Litigation-Related Activity
Litigation-related activities grew by 7%, showing consistent strength in dispute services, particularly in automotive and construction sectors.
Strategic Expansion in Key Areas
Exponent is actively engaged in early-stage initiatives tied to transformative innovations, including distributed energy systems and large-scale battery storage, presenting significant long-term growth opportunities.
Negative Updates
Decrease in Net Income and EBITDA
Net income for the second quarter decreased to $26.6 million ($0.52 per diluted share) from $29.2 million ($0.57 per diluted share) in the prior year. EBITDA decreased 7% to $37 million, with a margin drop to 27.8% from 30.2%.
Decline in Utilization and Billable Hours
Utilization dropped to 72.1% from 75.1%, with billable hours decreasing by 6% year-over-year, partly due to holiday timing and a step down in utilization.
Environmental and Health Segment Challenges
Net revenues in the environmental and health segment decreased by 4% due to lower activity in life sciences and chemical regulation services.
Increased Tax Rate and Operating Expenses
The consolidated tax rate increased to 27.9% from 26.3%, and other operating expenses rose by 8%, driven by noncash expense related to a lease extension.
Company Guidance
During Exponent's Second Quarter 2025 Earnings Conference Call, the company provided guidance indicating that revenues before reimbursements are expected to grow in the low single digits for the full year, with EBITDA projected to be between 26.5% to 27% of revenues before reimbursements. The company reported that total revenues increased by 1% to $142 million in Q2 2025, while net revenues remained flat at $132.9 million compared to the same period in 2024. Net income for the quarter decreased to $26.6 million or $0.52 per diluted share. The average number of technical full-time equivalent employees was down 2% year-over-year, though headcount is expected to increase by 4% by year-end. For the third quarter of 2025, Exponent anticipates revenues before reimbursements to rise in the mid-single digits and EBITDA margins to range from 26.75% to 27.75%. The company plans to maintain strategic recruitment efforts to support these growth targets and expects utilization to stabilize at approximately 72% for the full year.

Exponent Financial Statement Overview

Summary
Exponent demonstrates strong financial performance with robust profitability and stable growth. The company maintains a healthy balance sheet with effective leverage management and strong equity positions. Cash flow generation remains consistent, supporting ongoing operations and investments. Areas for improvement include maintaining gross profit margins and monitoring liabilities.
Income Statement
85
Very Positive
Exponent demonstrates strong profitability with a consistent net profit margin and improving EBIT and EBITDA margins. Revenue growth has been steady over recent years, indicating a solid upward trajectory. However, recent gross profit margins show slight fluctuations, which may need attention to maintain efficiency.
Balance Sheet
78
Positive
The balance sheet reflects solid financial health with a low debt-to-equity ratio, indicating prudent leverage management. The equity ratio is strong, ensuring stability. Return on Equity (ROE) is robust, showcasing effective utilization of equity to generate profits. Slight increases in liabilities should be monitored, but overall, the company maintains a healthy financial position.
Cash Flow
72
Positive
Exponent's cash flow position is strong, with consistent free cash flow generation. The operating cash flow to net income ratio is healthy, reflecting effective cash management. Although free cash flow growth shows some variability, the company maintains a stable cash flow foundation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue560.51M558.51M536.77M513.29M466.27M399.90M
Gross Profit318.06M142.28M135.76M164.50M124.21M96.14M
EBITDA146.72M129.25M120.24M147.92M115.41M90.12M
Net Income102.84M109.00M100.34M102.33M101.20M82.55M
Balance Sheet
Total Assets759.43M777.27M646.78M586.66M683.74M580.10M
Cash, Cash Equivalents and Short-Term Investments231.80M258.90M187.15M161.46M297.69M242.53M
Total Debt80.32M81.48M28.26M18.60M14.97M20.33M
Total Liabilities331.65M356.20M290.69M265.91M266.67M218.60M
Stockholders Equity427.78M421.07M356.08M320.75M417.06M361.50M
Cash Flow
Free Cash Flow120.92M137.60M111.00M81.76M117.74M98.33M
Operating Cash Flow129.26M144.54M127.35M93.81M124.57M103.31M
Investing Cash Flow-8.34M-6.94M-16.36M-12.04M38.18M5.02M
Financing Cash Flow-92.80M-65.11M-86.01M-215.98M-62.75M-88.36M

Exponent Technical Analysis

Technical Analysis Sentiment
Negative
Last Price68.03
Price Trends
50DMA
70.24
Negative
100DMA
72.91
Negative
200DMA
78.58
Negative
Market Momentum
MACD
-0.53
Positive
RSI
39.30
Neutral
STOCH
26.49
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EXPO, the sentiment is Negative. The current price of 68.03 is below the 20-day moving average (MA) of 69.64, below the 50-day MA of 70.24, and below the 200-day MA of 78.58, indicating a bearish trend. The MACD of -0.53 indicates Positive momentum. The RSI at 39.30 is Neutral, neither overbought nor oversold. The STOCH value of 26.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EXPO.

Exponent Risk Analysis

Exponent disclosed 34 risk factors in its most recent earnings report. Exponent reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Exponent Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$1.30B24.6528.70%0.99%9.28%44.19%
76
Outperform
$12.65B12.6097.54%2.09%9.25%75.69%
75
Outperform
$5.16B22.4213.14%-0.89%-23.72%
73
Outperform
$3.50B34.7425.05%1.73%3.47%-2.16%
72
Outperform
$2.55B25.7722.13%8.99%35.56%
71
Outperform
$1.73B16.4310.77%0.60%-0.47%10.03%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EXPO
Exponent
67.10
-43.90
-39.55%
BAH
Booz Allen
103.11
-55.21
-34.87%
CRAI
Cra International
195.84
17.00
9.51%
FCN
FTI Consulting
160.00
-62.44
-28.07%
HURN
Huron Consulting
150.32
44.67
42.28%
ICFI
Icf International
94.14
-70.83
-42.94%

Exponent Corporate Events

DividendsFinancial Disclosures
Exponent Declares Quarterly Dividend Amid Revenue Growth
Neutral
Jul 31, 2025

On July 31, 2025, Exponent, Inc. announced a quarterly cash dividend of $0.30 per share, to be paid on September 19, 2025, reflecting its commitment to returning value to shareholders. The company reported its second-quarter financial results for 2025, showing a slight increase in total revenues to $142.0 million, though net income decreased to $26.6 million compared to the previous year. Despite flat revenues, Exponent experienced growth in dispute-related activities in sectors like construction, automotive, and medical devices, while facing softer demand in chemical regulatory work. The firm is optimistic about opportunities in digital health, AI usability, and distributed energy systems, and anticipates continued growth in the second half of 2025.

Executive/Board ChangesShareholder Meetings
Exponent Holds Annual Stockholders Meeting on June 5
Neutral
Jun 10, 2025

On June 5, 2025, Exponent held its annual stockholders meeting, where key decisions were made regarding company governance and financial oversight. The stockholders elected six directors, including George H. Brown and Catherine Ford Corrigan, Ph.D., and ratified KPMG LLP as the independent registered public accounting firm for fiscal 2025. Additionally, the stockholders approved the executive compensation for fiscal 2024.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2025